Cargando…

Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers

Introduction  Chronic lymphocytic leukemia (CLL) is the commonest hematological malignancy in the West but is relatively uncommon in India. The prognosis of CLL is determined by well-established prognostic markers. CD49d has been emerging as a promising prognostic marker in CLL. CD49d expression in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunnumbrath, Arathi, Singh, Neha, Gupta, Arvind Kumar, Chowdhury, Nilotpal, Nath, Uttam Kumar, Chandra, Harish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750751/
https://www.ncbi.nlm.nih.gov/pubmed/36531546
http://dx.doi.org/10.1055/s-0042-1748828
_version_ 1784850325270691840
author Kunnumbrath, Arathi
Singh, Neha
Gupta, Arvind Kumar
Chowdhury, Nilotpal
Nath, Uttam Kumar
Chandra, Harish
author_facet Kunnumbrath, Arathi
Singh, Neha
Gupta, Arvind Kumar
Chowdhury, Nilotpal
Nath, Uttam Kumar
Chandra, Harish
author_sort Kunnumbrath, Arathi
collection PubMed
description Introduction  Chronic lymphocytic leukemia (CLL) is the commonest hematological malignancy in the West but is relatively uncommon in India. The prognosis of CLL is determined by well-established prognostic markers. CD49d has been emerging as a promising prognostic marker in CLL. CD49d expression in CLL has been found to have an aggressive clinical course, shorter time to first treatment, and poorer prognosis. The aim of this study was to analyze the flow cytometric expression of CD49d in newly diagnosed CLL and to correlate its expression with clinico-hematological parameters. Materials and Methods  Twenty-five consecutive patients of CLL, diagnosed on flow cytometry, were included in the study. Patients on treatment or those with relapse were excluded. The panel for flow cytometry included the routine markers used for CLL diagnosis along with CD49d. The expression of CD49d was correlated with clinico-hematological parameters in all patients. “R” software was used for the statistical analysis. Fisher's exact test and Wilcox test were used to assess the correlation of CD49d to categorical and continuous data, respectively. Results  The mean age of the patients was 62.6 ± 12.5 years, and 80% were symptomatic at diagnosis. CD49d expression was found in 44% cases, with a higher proportion being male patients. CD49d and prolymphocyte percentage showed a statistically significant correlation ( p  = 0.0007). We found a statistically significant correlation between CD49d expression and lymphadenopathy and splenomegaly with p -values of 0.033 and 0.0472, respectively. CD49d positivity correlated significantly with a higher Rai stage ( p  = 0.0196) and intermediate and high-risk cases according to Binet staging ( p  = 0.033). Conclusion  CD49d expression in the present study correlated with a higher prolymphocyte percentage, lymphadenopathy, splenomegaly, and higher Rai and Binet stages. CD49d expression on flow cytometry was reproducible and easy to interpret.
format Online
Article
Text
id pubmed-9750751
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97507512022-12-15 Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers Kunnumbrath, Arathi Singh, Neha Gupta, Arvind Kumar Chowdhury, Nilotpal Nath, Uttam Kumar Chandra, Harish J Lab Physicians Introduction  Chronic lymphocytic leukemia (CLL) is the commonest hematological malignancy in the West but is relatively uncommon in India. The prognosis of CLL is determined by well-established prognostic markers. CD49d has been emerging as a promising prognostic marker in CLL. CD49d expression in CLL has been found to have an aggressive clinical course, shorter time to first treatment, and poorer prognosis. The aim of this study was to analyze the flow cytometric expression of CD49d in newly diagnosed CLL and to correlate its expression with clinico-hematological parameters. Materials and Methods  Twenty-five consecutive patients of CLL, diagnosed on flow cytometry, were included in the study. Patients on treatment or those with relapse were excluded. The panel for flow cytometry included the routine markers used for CLL diagnosis along with CD49d. The expression of CD49d was correlated with clinico-hematological parameters in all patients. “R” software was used for the statistical analysis. Fisher's exact test and Wilcox test were used to assess the correlation of CD49d to categorical and continuous data, respectively. Results  The mean age of the patients was 62.6 ± 12.5 years, and 80% were symptomatic at diagnosis. CD49d expression was found in 44% cases, with a higher proportion being male patients. CD49d and prolymphocyte percentage showed a statistically significant correlation ( p  = 0.0007). We found a statistically significant correlation between CD49d expression and lymphadenopathy and splenomegaly with p -values of 0.033 and 0.0472, respectively. CD49d positivity correlated significantly with a higher Rai stage ( p  = 0.0196) and intermediate and high-risk cases according to Binet staging ( p  = 0.033). Conclusion  CD49d expression in the present study correlated with a higher prolymphocyte percentage, lymphadenopathy, splenomegaly, and higher Rai and Binet stages. CD49d expression on flow cytometry was reproducible and easy to interpret. Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-06-10 /pmc/articles/PMC9750751/ /pubmed/36531546 http://dx.doi.org/10.1055/s-0042-1748828 Text en The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Kunnumbrath, Arathi
Singh, Neha
Gupta, Arvind Kumar
Chowdhury, Nilotpal
Nath, Uttam Kumar
Chandra, Harish
Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers
title Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers
title_full Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers
title_fullStr Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers
title_full_unstemmed Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers
title_short Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers
title_sort flow cytometric expression of cd49d in newly diagnosed chronic lymphocytic leukemia and its correlation with established prognostic markers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750751/
https://www.ncbi.nlm.nih.gov/pubmed/36531546
http://dx.doi.org/10.1055/s-0042-1748828
work_keys_str_mv AT kunnumbratharathi flowcytometricexpressionofcd49dinnewlydiagnosedchroniclymphocyticleukemiaanditscorrelationwithestablishedprognosticmarkers
AT singhneha flowcytometricexpressionofcd49dinnewlydiagnosedchroniclymphocyticleukemiaanditscorrelationwithestablishedprognosticmarkers
AT guptaarvindkumar flowcytometricexpressionofcd49dinnewlydiagnosedchroniclymphocyticleukemiaanditscorrelationwithestablishedprognosticmarkers
AT chowdhurynilotpal flowcytometricexpressionofcd49dinnewlydiagnosedchroniclymphocyticleukemiaanditscorrelationwithestablishedprognosticmarkers
AT nathuttamkumar flowcytometricexpressionofcd49dinnewlydiagnosedchroniclymphocyticleukemiaanditscorrelationwithestablishedprognosticmarkers
AT chandraharish flowcytometricexpressionofcd49dinnewlydiagnosedchroniclymphocyticleukemiaanditscorrelationwithestablishedprognosticmarkers